News Channels

24 Mar 2020 AveXis presents AVXS-101 IT data demonstrating remarkable increases in HFMSE scores and a consistent clinically meaningful response in older patients with SMA Type 2
24 Mar 2020 Zolgensma® data shows rapid, significant, clinically meaningful benefit in SMA including prolonged event-free survival, motor milestone achievement and durability now up to 5 years post-dosing
24 Mar 2020 Pieris Pharmaceuticals Provides Update on Servier Collaboration
24 Mar 2020 Secarna Pharmaceuticals announces the acquisition of LNAplus based antisense drug candidates by Lipigon Pharmaceuticals
23 Mar 2020 Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States
23 Mar 2020 Regulatory authorities approve JTA Phase III study in osteoarthritic knee pain and ALLOB Phase IIb study in difficult fractures
23 Mar 2020 Agios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator
23 Mar 2020 Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders
23 Mar 2020 Sorrento and Smartpharm to collaborate to develop novel gene-encoded antibody vaccine intended to protect against COVID-19
23 Mar 2020 Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis
23 Mar 2020 Hoth Therapeutics Announces Agreement to Joint Development for a Self-Assembling Vaccine (SAV) for the Potential Prevention of the Coronavirus (COVID-19)
23 Mar 2020 NeoImmuneTech Enters into Exclusive License Agreement with Ubix Therapeutics to Develop Drug Candidates Including T Cell Suppressor Blockade
23 Mar 2020 Celltrion Accelerates Development of COVID-19 Antiviral Treatment and Aims to Launch Rapid Self-testing Kit
23 Mar 2020 AlloVir Expands Its Research Collaboration with Baylor College of Medicine to Discover and Develop Allogeneic, Off-the-Shelf, Virus-Specific T-Cell Therapies for COVID-19
23 Mar 2020 AbbVie Announces Positive Topline Results from Phase 3 Trial of VENCLEXTA® (venetoclax) in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML)
23 Mar 2020 Genentech Announces FDA Approval of Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumonia
23 Mar 2020 COVID-19 vaccine development
23 Mar 2020 Bayer and Curadev sign research collaboration and license agreement to develop novel STING antagonists across indications
23 Mar 2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy
22 Mar 2020 Zealand Pharma regains worldwide rights to Amylin analog program from Boehringer Ingelheim

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up